agespecif
preval
cf
antibodi
viral
antigen
determin
use
computer
data
registri
routin
diagnost
laboratori
author
depart
materi
consist
data
base
serum
specimen
patient
age
newborn
infant
repres
sera
collect
test
cf
screen
test
period
year
sever
differ
antibodi
preval
pattern
distinguish
regard
rapid
time
initi
increas
preval
well
mode
later
chang
preval
respiratori
virus
rapid
increas
preval
seen
childhood
continu
influenza
coronaviru
rather
variabl
pattern
found
older
age
group
herp
simplex
cytomegalovirus
show
interestingli
anoth
type
pattern
slow
increas
preval
continu
whole
age
rang
frequenc
herp
simplex
antibodi
reach
age
year
antibodi
level
antigen
infant
less
onemonthold
equal
adult
expect
rapid
decreas
antibodi
took
place
within
first
month
life
possibl
influenc
epidem
repeat
exposur
differ
virus
extern
boost
latent
chronic
infect
intern
boost
well
technic
variat
observ
preval
pattern
discuss
alreadi
mani
serolog
survey
describ
agespecif
frequenc
viral
antibodi
gener
preval
viral
antibodi
popul
seem
increas
advanc
age
childhood
teen
gradual
decreas
older
peopl
howev
older
studi
limit
small
number
studi
sera
age
group
birth
senesc
usual
includ
also
sera
may
repres
whole
underli
popul
gener
coupl
viral
antigen
use
one
studi
therefor
difficult
compar
seroepidemiolog
differ
viral
infect
data
routin
diagnost
laboratori
author
depart
store
comput
sinc
ukkonen
et
al
complement
fixat
cf
serolog
screen
test
antigen
perform
annual
patient
year
apart
immedi
benefit
effect
find
specif
diagnosi
broad
coverag
screen
test
like
provid
valuabl
epidemiolog
inform
present
paper
report
agespecif
preval
viral
antibodi
year
may
reveal
age
infect
differ
virus
mainli
occur
also
attempt
correl
yeartoyear
chang
antibodi
preval
known
occurr
respect
viral
diseas
similar
analysi
materi
mycoplusma
pneumonia
ponka
ukkonen
chlamydia
antibodi
report
separ
depart
respons
studi
blood
specimen
drawn
finland
serolog
diagnosi
viral
infect
specimen
come
differ
hospit
remaind
outpati
clinic
geograph
part
countri
well
cover
except
southwestern
district
serv
anoth
major
laboratori
therefor
patient
repres
fairli
well
gener
finnish
popul
present
studi
base
data
collect
screen
test
cf
antibodi
year
data
obtain
comput
file
describ
ukkonen
et
al
total
number
patient
studi
result
present
group
four
period
consist
ooo
patient
age
group
one
period
patient
tabl
number
patient
test
vari
differ
antigen
antigen
temporarili
absent
screen
test
tabl
diseas
whose
symptom
might
caus
sever
differ
agent
respiratori
infect
clinician
usual
choos
complement
fixat
screen
test
test
second
specimen
pair
sera
case
singl
serum
avail
assay
dilut
complement
fixat
viral
antigen
mycoplmma
pneumonia
chlamydia
toxoplasma
antigen
specimen
posit
test
dilut
titrat
least
case
pair
sera
togeth
first
specimen
present
studi
test
result
second
serum
specimen
use
pair
sera
avail
year
studi
age
group
age
group
age
group
age
group
age
group
age
group
age
group
age
group
chorioallanto
membran
cell
santigen
chorioallanto
membran
cell
santigen
allanto
fluid
vantigen
chorioallanto
membran
cell
test
perform
microtitr
plate
describ
riski
et
al
two
unit
complement
four
unit
antigen
use
first
specimen
dilut
studi
result
express
preval
antibodi
titer
crude
antigen
prepar
use
tabl
iii
case
antigen
deriv
cell
cultur
infect
cell
full
cytopath
effect
broken
repeat
freez
thaw
centrifug
sonic
adenoviru
antigen
use
prepar
cultur
medium
instead
infect
cell
chorioallanto
membran
influenza
b
parainfluenza
type
santigen
chicken
embryo
infect
day
homogen
ultracentrifug
concentr
supernat
use
cf
antigen
mump
parainfluenza
type
vantigen
allanto
fluid
chicken
embryo
infect
day
respect
number
virolog
viru
isol
serolog
diagnos
case
finland
year
fig
obtain
file
central
public
health
laboratori
helsinki
preval
cf
antibodi
titer
infant
less
month
old
equal
slightli
less
adult
age
year
group
includ
femal
childbear
age
follow
month
proport
posit
reactor
rapidli
decreas
reflect
loss
transplacent
acquir
matern
antibodi
fig
rotaviru
antibodi
found
often
infant
less
month
old
adult
could
indic
mother
small
children
higher
level
rotaviru
antibodi
peopl
age
possibl
due
frequent
exposur
rotaviru
infect
children
anoth
possibl
higher
preval
antibodi
children
reflect
frequent
rotaviru
infect
newborn
differ
respiratori
virus
influenza
b
parainfluenza
type
respiratori
syncyti
coronaviru
show
antibodi
preval
pattern
mani
similar
also
contain
certain
differ
rapid
increas
preval
took
place
childhood
antibodi
parainfluenza
respiratori
syncyti
virus
reach
respect
peak
preval
valu
age
year
preval
antibodi
influenzavirus
coronavirus
continu
increas
earli
adulthood
fig
yeartoyear
differ
preval
pattern
typic
antigen
comment
follow
preval
influenza
antibodi
show
increas
age
group
fig
increas
seen
alreadi
figur
shown
like
explan
chang
given
main
epidemiolog
featur
finland
studi
period
follow
epidem
caus
type
epidem
occur
moder
size
epidem
took
place
everi
year
epidem
caus
mainli
type
previou
epidem
due
type
pyhala
visakorpi
increas
preval
influenza
b
antibodi
fig
document
epidem
observ
overal
antibodi
preval
score
may
simpl
fig
name
increas
antibodi
preval
start
alreadi
year
document
influenza
b
case
countri
unlik
influenza
virus
preval
antibodi
detect
parainfluenza
type
antigen
began
decreas
year
age
fig
rel
low
level
antibodi
obtain
type
antigen
may
due
differ
antigen
prepar
compar
use
tabl
iii
fall
antibodi
preval
parainfluenza
antigen
appar
relat
use
antigen
instead
v
antigen
tabl
comparison
previou
studi
difficult
perform
neutral
haemagglutin
inhibit
test
age
group
repres
golubjatnikov
et
al
jen
jensen
et
al
parrott
et
al
frequenc
antibodi
respiratori
syncyti
viru
rsv
character
rapid
increas
age
year
slight
decreas
adult
fig
observ
accord
known
epidemiolog
rsv
caus
major
ill
infant
elderli
peopl
spread
age
group
epidem
mostli
subclin
infect
cooney
et
ai
henderson
et
al
parrott
et
al
epidem
rsv
infect
occunwl
finland
everi
second
year
rhe
studi
period
epidem
probabl
caus
observ
increas
antibodi
preval
age
group
overal
posit
fig
studi
rsv
antibodi
cf
haqe
result
differ
frequenc
hornsleth
volkert
found
antibodi
age
year
hand
almost
ident
preval
pattern
compar
investig
report
london
hambl
differ
like
due
presenc
absenc
widespread
epidem
studi
clearli
seen
materi
cover
period
year
interest
note
despit
appar
heavi
epidem
preval
rsv
antibodi
decreas
steadili
one
explan
might
document
rsv
case
last
epidem
southwestern
district
finland
serv
laboratori
antibodi
coronaviru
reach
high
preval
age
year
fig
show
coronaviru
infect
common
occur
long
period
life
infect
appar
mild
explain
unexpectedli
low
number
serolog
diagnos
infect
contrast
high
antibodi
preval
riski
hovi
preval
mump
antibodi
differ
slightli
parainfluenza
viru
antibodi
rapid
increas
start
month
tend
continu
year
age
thereaft
preval
slowli
decreas
fig
conscript
defenc
forc
around
age
year
penttinen
et
al
observ
similar
parainfluenza
virus
somewhat
unexpect
mump
infect
thought
induc
lifelong
immun
case
wherea
parainfluenza
virus
howev
persist
cf
antibodi
mump
may
indic
repeat
extern
boost
contact
viru
irrespect
clinic
immun
statu
similar
antibodi
frequenc
paramyxovirus
may
also
partli
due
antigen
crossreact
demeio
walker
lennett
et
al
penttinen
cantel
two
epidem
mump
studi
period
former
epidem
preced
low
preval
antibodi
follow
expect
increas
preval
number
age
group
fig
latter
epidem
increas
antibodi
preval
clearli
seen
children
month
year
age
fig
although
mump
infect
characterist
clinic
symptom
parot
mening
common
age
howev
known
children
year
mump
viru
infect
often
present
respiratori
symptom
cooney
et
al
therefor
may
recogn
mump
measl
antibodi
preval
differ
paramyxovirus
two
respect
practic
interannu
variat
distinct
decreas
preval
occur
age
year
fig
first
featur
suggest
antigen
much
chang
studi
period
hand
agreement
fact
measl
constantli
circul
popul
instead
caus
intermitt
widespread
epidem
declin
antibodi
preval
adult
agreement
result
followup
studi
cf
antibodi
titer
lower
significantli
first
year
measl
infect
pech
vaccin
children
live
measl
vaccin
began
finland
children
vaccin
age
month
effect
vaccin
preval
curv
earlier
increas
preval
appar
age
group
year
year
vs
antibodi
adenoviru
appear
earli
year
age
increas
preval
anoth
characterist
featur
promin
de
creas
antibodi
frequenc
adult
begin
age
year
fig
drop
even
steeper
found
measl
antibodi
similar
trend
adenoviru
antibodi
also
report
jamaica
jen
result
could
suggest
extern
boost
like
occur
age
adenoviru
infect
common
popul
longer
stimul
cf
antibodi
format
older
age
group
neutral
antibodi
probabl
present
adult
may
prevent
boost
cf
antibodi
hand
decreas
contact
children
may
also
result
fewer
extern
boost
occas
older
age
group
antibodi
rotaviru
found
rel
low
frequenc
contrast
common
occurr
rotaviru
infect
childhood
fig
suggest
cf
antibodi
short
durat
hand
regularli
develop
gastroenter
caus
rotaviru
von
bonsdorff
et
al
materi
rotaviru
antibodi
acquir
somewhat
later
previou
studi
similar
antigen
placklow
et
al
although
maxim
preval
rather
low
age
year
minim
frequenc
loss
matern
antibodi
remain
rel
high
compar
antivir
antibodi
agreement
frequent
occurr
rotaviru
infect
earli
childhood
period
increas
antibodi
preval
shorter
year
age
antigen
studi
fig
antibodi
preval
measur
coxsacki
antigen
reveal
pattern
similar
observ
adenoviru
suggest
enteroviru
infect
common
first
year
life
popul
fig
overal
increas
antibodi
preval
probabl
caus
improv
antigen
prepar
number
virolog
diagnos
diseas
caus
enterovirus
chang
studi
year
shown
poliomyel
case
occur
finland
sinc
finnish
children
vaccin
inactiv
polio
viru
vaccin
type
l
year
therefor
antibodi
measur
polio
cf
antigen
fig
part
rais
vaccin
enteroviru
infect
may
also
contribut
antibodi
preval
measur
polio
viru
complement
fixat
test
antigen
crossreact
herp
simplex
viru
antibodi
herp
simplex
viru
uniqu
preval
pattern
antibodi
acquir
rel
rapidli
month
year
age
increas
slow
continu
age
year
patient
antibodi
fig
similar
pattern
report
investig
holzel
et
al
smith
et
al
wentworth
alexand
although
oldest
age
group
includ
studi
continu
increas
herp
simplex
antibodi
frequenc
fit
well
fact
primari
infect
viru
remain
latent
nervou
system
case
latent
infect
rather
reactiv
seem
booster
effici
cf
antibodi
format
anoth
distinct
featur
virtual
annual
variat
antibodi
preval
occur
year
indic
nonepidem
natur
herp
simplex
infect
well
stabil
cf
test
herp
simplex
antibodi
varicellazost
viru
antibodi
preval
gener
low
compar
fact
peopl
varicella
childhood
fig
cf
antibodi
must
disappear
rapidli
primari
infect
therefor
cf
test
poor
indic
past
varicella
infect
previou
studi
increas
antibodi
preval
observ
old
peopl
patient
includ
age
group
therefor
result
may
repres
whole
popul
tomlinson
maccallum
higher
antibodi
frequenc
adult
report
author
wentworth
alexand
tomlinson
maccallum
big
differ
within
studi
also
seen
year
variat
probabl
caus
chang
antigen
use
tabl
jii
rather
epidemiolog
circumst
cytomegaloviru
slow
late
acquisit
cytomegaloviru
antibodi
fig
similar
report
earlier
hanshaw
leiniklu
et
al
stern
et
al
wentworth
alexand
increas
antibodi
preval
appear
two
age
short
period
rise
antibodi
observ
month
year
age
preval
remain
steadi
teen
age
anoth
period
increas
antibodi
frequenc
took
place
cytomegaloviru
known
infect
peopl
primarili
year
age
leinikki
et
al
agreement
first
peak
preval
curv
thereaft
increas
antibodi
frequenc
taken
reflect
primari
cytomegaloviru
infect
may
result
boost
effect
reactiv
infect
increas
preval
year
age
probabl
associ
sexual
activ
hormon
chang
eg
pregnanc
may
also
play
role
may
well
member
herpesviru
group
primari
infect
induc
longlast
cf
antibodi
rel
late
increas
antibodi
posit
materi
reflect
accumul
effect
sever
booster
come
intern
reactiv
latent
infect
case
varicellazost
herp
simplex
cytomegaloviru
possibl
extern
repeat
exposur
varicella
school
age
herp
simplex
cytomegaloviru
increas
sexual
activ
chang
methodolog
import
factor
affect
result
survey
cover
period
sever
year
studi
cf
test
perform
laboratori
work
procedur
mani
case
ident
antigen
prepar
whole
period
good
indic
stabil
princip
method
preval
herp
simplex
viru
antibodi
sinc
agespecif
preval
unchang
year
great
interannu
variat
antigen
without
obviou
epidemiolog
reason
interpret
difficulti
standard
antigen
group
poor
antigen
would
includ
parainfluenza
coxsacki
polio
varicellazost
cytomegaloviru
antigen
level
antibodi
posit
howev
essenti
survey
instead
preval
pattern
consid
inform
point
irrespect
vari
overal
antibodi
preval
agespecif
preval
pattern
significantli
chang
year
exemplifi
cytomegaloviru
antibodi
although
serum
sampl
studi
obtain
patient
suspect
viral
infect
consid
gener
popul
fairli
well
repres
preval
antivir
antibodi
rational
base
use
screen
test
nearli
viral
antigen
percentag
recent
infect
caus
given
viru
studi
neglig
screen
test
appli
diagnosi
great
number
differ
infect
comput
file
found
total
number
acut
viral
infect
rise
antibodi
titer
pair
sera
materi
common
diagnosi
influenza
account
patient
viru
diagnos
found
less
patient
mean
case
influenza
patient
recent
influenza
infect
time
studi
could
regard
normal
popul
respect
percentag
virus
furthermor
patient
select
socioeconom
class
due
public
health
care
system
finland
laboratori
serv
type
hospit
polyclin
repres
twothird
whole
popul
howev
fact
patient
hospit
outpati
clinic
diminish
valu
materi
repres
normal
popul
may
result
erron
interpret
result
viral
antigen
antibodi
level
cf
known
decreas
rel
soon
primari
infect
therefor
period
increas
antibodi
preval
might
consid
reflect
age
infect
mainli
occur
summark
fig
primari
reinfect
may
contribut
part
preval
curv
persist
antibodi
adult
much
difficult
explain
probabl
net
result
sever
factor
typic
infect
agent
factor
includ
capabl
induc
chronic
latent
recur
infect
herp
group
repeat
epidem
exposur
influenza
b
antigen
crossreact
paramyxovirus
enterovirus
clear
neutral
test
probabl
radioimmunoassay
enzym
immunoassay
would
proper
method
determin
cumul
proport
popul
experienc
given
viru
infect
spite
variat
overal
antibodi
preval
characterist
agespecif
preval
pattern
given
viral
antibodi
remain
fairli
constant
year
year
pattern
typic
antigen
evid
figur
arbitrarili
arrang
group
summari
tabl
tabl
iv
specif
pattern
shown
herpesvirus
explain
uniqu
biolog
featur
virus
whether
modest
differ
pattern
antibodi
preval
antigen
reflect
true
biolog
differ
respect
viral
infect
judg
avail
inform
